Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 27, 2026, titled "Zydus Lifesciences announces successful clinical development of Pembrolizumab biosimilar FYB206, marking a milestone toward USFDA filing".
Press Release Feb 27 2026
Filed with NSE · · 3 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Feb 25 2026
- Press Release Feb 19 2026
- Press Release Feb 18 2026
- Press Release Feb 17 2026
- Press Release Feb 14 2026
Later from Zydus Lifesciences
- Press Release Feb 28 2026
- Press Release Mar 12 2026
- Press Release Mar 13 2026
- Press Release Mar 14 2026
- Press Release Mar 16 2026
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences